• Price (EUR)452.45
  • Today's Change11.25 / 2.55%
  • Shares traded0.00
  • 1 Year change-2.17%
  • Beta--
Data delayed at least 15 minutes, as of Feb 03 2023.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. It also offers human medical point-of-care & laboratory diagnostics. Its products include health monitoring, others. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment CAG develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry.

  • Revenue in USD (TTM)3.34bn
  • Net income in USD669.65m
  • Incorporated1983
  • Employees10.35k
  • Location
    IDEXX Laboratories IncOne Idexx DriveWESTBROOK 04092-2041United StatesUSA
  • Phone+1 (207) 556-0300
  • Fax+1 (207) 556-4346
  • Websitehttps://www.idexx.com/
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.